View Full Version : NATURE Publishes New Dynavax Findings On Novel Role Of TLRs In Lupus

06-17-2010, 09:14 AM
Dynavax Technologies Corporation (NASDAQ: DVAX) today reported in NATURE new data that may explain the resistance of lupus patients to glucocorticoid treatment. In the June 16, 2010 issue of NATURE, Dynavax scientists show that activation of cells of the innate immune system by two key receptors, TLR7 and TLR9, can cause glucocorticoid resistance in lupus patients...

More... (http://mnt.to/f/3F2k)

06-17-2010, 06:05 PM
Hmmm..still not quite ready for Lupus patients but interesting!